Currently set to Index
Currently set to Follow
Condition. Cancer pain
November 25, 2021
0
0
What is cancer pain? There are many types of cancer pain. Cancer pain can be achy, burning, dull, or sharp. Also, it can be intermittent or constant, moderate or severe. The severity of cancer pain depends on such factors as the type of cancer, how advanced your cancer is, your pain tolerance, the location of […]
Read more
Treatment. Cancer Pain
November 23, 2021
0
0
Cancer pain diagnosis First of all, your doctor may perform a physical exam to identify the pain origin. The description of your pain is crucial in understanding its character (dull, achy, sharp, shooting) and intensity (mild, moderate, severe). Cancer pain treatment methods There are a number of treatment methods that are available for cancer pain […]
Read more
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study
November 16, 2021
0
0
Taro Iguchi 1, Satoshi Tamada 2, Minoru Kato 2, Sayaka Yasuda 2, Yuichi Machida 3, Tetsuji Ohmachi 4, Keiichi Ishii 5, Hiroyuki Iwata 6, Shinji Yamamoto 7, Tomohiro Kanamaru 8, Kazuya Morimoto 9, Taro Hase 10, Koichiro Tashiro 11, Koji Harimoto 12, Takashi Deguchi 13, Takahisa Adachi 14, Katsuki Iwamoto 15, Yoshinori Takegaki 16, Tatsuya […]
Read more
Promoting integrated care in prostate cancer through online prostate cancer-specific holistic needs assessment: a feasibility study in primary care
November 16, 2021
0
0
Amy L Clarke 1, Julia Roscoe 1, Rebecca Appleton 1, Deepak Parashar 2 3 4, Radha Muthuswamy 5, Omar Khan 1, Jeremy Dale 1, Veronica Nanton Main idea: While the study demonstrated the feasibility of implementing the specific holistic needs assessment, it did not meet the a priori progression criteria; as such, undertaking a definitive […]
Read more
The diagnostic value of miRNA-141 in prostate cancer: A systematic review and PRISMA-compliant meta-analysis
November 16, 2021
0
0
Yun Ye 1, Xiao-Hua Yuan 1, Jian-Jun Wang 2, Yu-Chen Wang 1, Su-Liang Li 1 Main idea: This meta-analysis suggests that miR-141 has a high diagnostic value for prostate cancer. In the future, large-scale prospective studies are needed to verify and evaluate this result. Abstract Background: miR-141 has gradually demonstrated its value in the diagnosis […]
Read more
Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis
November 16, 2021
0
0
Edoardo Carli 1, Gian Paolo Caviglia 2, Rinaldo Pellicano 3, Sharmila Fagoonee 4, Stefano Rizza 1, Marco Astegiano 3, Giorgio Maria Saracco 1, Davide Giuseppe Ribaldone Main idea: Patients with IBD appear to have a slightly increased risk of PC compared to the general population. Abstract Background and objectives: Inflammatory bowel disease (IBD) is associated […]
Read more
Association between interleukin-8 rs4073 polymorphism and prostate cancer: A meta-analysis
November 16, 2021
0
0
Chih-Heng Chen 1, Chen-Hsun Ho 2, Su-Wei Hu 1, Kai-Yi Tzou 3, Yuan-Hung Wang 4, Chia-Chang Wu Main idea: The major findings of this meta-analysis suggested that IL-8 rs4073 polymorphism is significantly associated with risk of prostate cancer. Abstract Background/purpose: Interleukin-8 (IL-8) is an inflammatory cytokine and plays important role in development of cancers. We […]
Read more
Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis
November 16, 2021
0
0
Zin W Myint 1 2, Harry D Momo 2, Danielle E Otto 2 3, Donglin Yan 2, Peng Wang 1 2, Jill M Kolesar Main idea: Use of androgen receptor inhibitors was associated with an increase in falls and fractures in patients with prostate cancer as assessed by a retrospective systematic review and meta-analysis. Further […]
Read more